Bernhard Reis, L. Jukofsky, Gong Chen
May 1, 2016
Citations
0
Influential Citations
76
Citations
Quality indicators
Journal
Haematologica
Abstract
In translational research described, we investigated biomarker expression by flow cytometry for MDM2 antagonist clinical response association in relapsed/refractory AML patients treated with idasanutlin-based therapy ( [Clinicaltrials.gov][1] identifier: [NCT01773408][2] ). As MDM2 targets p53 for